Advertisement

Scharioth Macula Lens

  • Gabor B. SchariothEmail author
Chapter

Abstract

Age-related macular degeneration has a high prevalence in industrialized societies and is the most common cause for loss of reading vision among patients older then 55 years of age [1, 2]. In recent years major advances have been made in the therapy of the neovascular form of age-related macular degeneration [1, 3, 4], but reduced near visual acuity is still a major problem for all forms of age-related macular degeneration. External magnifying low visual aids are known for decades, but uncomfortable use and stigmatization in public limited their acceptance. They might affect the visual field and cannot be worn continuously. Furthermore they might be forgotten at home, lost or damaged.

Keywords

Cataract Surgery Reading Distance Ciliary Sulcus Secondary Cataract Neovascular Form 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Supplementary material

Video 10.1

AddOn SML (Scharioth Macula Lens)-SD (MP4 13963 kb)

References

  1. 1.
    Martin DF, Maguire MG, Fine SL, et al. Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results. Ophthalmology. 2012;119(7):1388–98.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Congdon N, O'Colmain B, Klaver CC, et al. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol. 2004;122(4):477–85.CrossRefPubMedGoogle Scholar
  3. 3.
    Rosenfeld PJ, Brown DM, Heier JS, et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2006;355(14):1419–31.CrossRefPubMedGoogle Scholar
  4. 4.
    Heier JS, Brown DM, Chong V, et al. Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration. Ophthalmology. 2012;119(12):2537–48.CrossRefPubMedGoogle Scholar
  5. 5.
    Lipshitz I, Loewenstein A, Reingewiirtz M, et al. An intraocular telescopic lens for macular degeneration. Ophthalmic Surg Lasers. 1997;28(6):513–7.PubMedGoogle Scholar
  6. 6.
    Lane SS, Kuppermann BD, Fine IH, et al. A prospective multicenter clinical trail to evaluate safety and effectiveness of the implantable miniature telescope. Am J Ophthalmol. 2004;137(6):993–1001.CrossRefPubMedGoogle Scholar
  7. 7.
    Agarwal AI, Lipshitz I, Jacob S, et al. Mirror telescopic intraocular lens for age-related macular degeneration: design and prelimanary clinical results of the Lipshitz macular implant. J Cataract Refract Surg. 2008;34(I):87–94.CrossRefPubMedGoogle Scholar
  8. 8.
    Qureshi MA, Robbie SJ, Tabernero J, Artal P. Injectable intraocular telescope: pilot study. J Cataract Refract Surg. 2015;41(10):2125–35.CrossRefPubMedGoogle Scholar
  9. 9.
    Scharioth GB. New add-on intraocular lens for patients with age-related macular degeneration. J Cataract Refract Surg. 2015;41(8):1559–63.CrossRefPubMedGoogle Scholar
  10. 10.
    Sauder G, Cordes A. Scope of applications and experience record with a new generation of add-on IOLs: the A4 W lens. Ophthalmo-Chirurgie. 2012;24(Suppl. 2):1–6.Google Scholar
  11. 11.
    Scharioth GB. Add-on IOLs for vitrectomized silicone oil-filled eyes. Retinal Physicians. 2014;11:31–3.Google Scholar

Copyright information

© Springer International Publishing AG 2017

Authors and Affiliations

  1. 1.Aurelis AugenzentrumRecklinghausenGermany

Personalised recommendations